Padula Amy M, Yang Wei, Schultz Kathleen, Tom Lauren, Lin Bin, Carmichael Suzan L, Lammer Edward J, Shaw Gary M
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, California.
Department of Pediatrics, Stanford University School of Medicine, California.
Am J Med Genet A. 2016 Nov;170(11):2788-2802. doi: 10.1002/ajmg.a.37883. Epub 2016 Sep 12.
In a population-based case-control study in California of 228 infants, we investigated 75 genetic variants in 20 genes and risk of gastroschisis with regard to maternal age, race/ethnicity, vitamin use, and smoking exposure. We hypothesized that genes related to vascular compromise may interact with environmental factors to affect the risk of gastroschisis. Haplotypes were constructed for 75 gene variants using the HaploView program. Risk for gastroschisis associated with each gene variant was calculated for both the homozygotes and the heterozygotes, with the homozygous wildtypes as the referent. Risks were estimated as odds ratios (ORs) with 95% confidence intervals (CIs) by logistic regression. We found 11 gene variants with increased risk and four variants with decreased risk of gastroschisis for heterozygous (OR ) or homozygous variants (OR ) genotypes. These included NOS3 (rs1036145) OR = 0.4 (95% CI: 0.2-0.7); NOS3 (rs10277237) OR = 2.7 (95% CI: 1.3-6.0); ADD1 (rs12503220) OR = 2.9 (95% CI: 1.6-5.4), GNB3 (rs5443) OR = 0.2 (95% CI: 0.1-0.5), OR = 0.4 (95% CI: 0.2-0.9); ICAM1 (rs281428) OR = 6.9 (95% CI: 2.1-22.9), ICAM1 (rs3093030) OR = 2.6 (95% CI: 1.2-5.6); ICAM4 (rs281438) OR = 4.9 (95% CI: 1.4-16.6), ICAM5 (rs281417) OR = 2.1 (95% CI: 1.1-4.1), OR = 4.8 (95% CI: 1.7-13.6); ICAM5 (rs281440) OR = 23.7 (95% CI: 5.5-102.5), OR = 20.6 (95% CI: 3.4-124.3); ICAM5 (rs2075741) OR = 2.2 (95% CI: 1.1-4.4); NAT1 OR = 0.3 (95% CI: 0.1-0.9). There were additional associations between several gene variants and gastroschisis among women aged 20-24 and among mothers with and without vitamin use. NOS3, ADD1, ICAM1, ICAM4, and ICAM5 warrant further investigation in additional populations and with the interaction of additional environmental exposures. © 2016 Wiley Periodicals, Inc.
在加利福尼亚州一项基于人群的病例对照研究中,我们调查了228名婴儿,研究了20个基因中的75个基因变异以及腹裂风险与产妇年龄、种族/民族、维生素使用情况和吸烟暴露之间的关系。我们假设与血管受损相关的基因可能与环境因素相互作用,从而影响腹裂风险。使用HaploView程序构建了75个基因变异的单倍型。计算了纯合子和杂合子中每个基因变异与腹裂相关的风险,以纯合野生型作为对照。通过逻辑回归将风险估计为比值比(OR)及95%置信区间(CI)。我们发现11个基因变异使杂合子(OR)或纯合子变异(OR)基因型的腹裂风险增加,4个变异使其风险降低。这些基因包括一氧化氮合酶3(NOS3,rs1036145),OR = 0.4(95% CI:0.2 - 0.7);NOS3(rs10277237),OR = 2.7(95% CI:1.3 - 6.0);α-内收蛋白1(ADD1,rs12503220),OR = 2.9(95% CI:1.6 - 5.4);鸟嘌呤核苷酸结合蛋白β3(GNB3,rs5443),OR = 0.2(95% CI:0.1 - 0.5),OR = 0.4(95% CI:0.2 - 0.9);细胞间黏附分子1(ICAM1,rs281428),OR = 6.9(95% CI:2.1 - 22.9);ICAM1(rs3093030),OR = 2.6(95% CI:1.2 - 5.6);细胞间黏附分子4(ICAM4,rs281438),OR = 4.9(95% CI:1.4 - 16.6);细胞间黏附分子5(ICAM5,rs281417),OR = 2.1(95% CI:1.1 - 4.1),OR = 4.8(95% CI:1.7 - 13.6);ICAM5(rs281440),OR = 23.7(95% CI:5.5 - 102.5),OR = 20.6(95% CI:3.4 - 124.3);ICAM5(rs2075741),OR = 2.2(95% CI:1.1 - 4.4);N-乙酰基转移酶1(NAT1),OR = 0.3(95% CI:0.1 - 0.9)。在20 - 24岁的女性以及使用和未使用维生素的母亲中,几种基因变异与腹裂之间还存在其他关联。NOS3、ADD1、ICAM1、ICAM4和ICAM5需要在更多人群中以及与其他环境暴露的相互作用方面进行进一步研究。© 2016威利期刊公司